We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+6.7%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$164B
AUM Growth
+$34B
Cap. Flow
+$21.1B
Cap. Flow %
12.82%
Top 10 Hldgs %
19.02%
Holding
8,908
New
1,440
Increased
3,569
Reduced
2,696
Closed
988

Sector Composition

Rank Sector Weight
1 Technology 6.22%
2 Financials 6.16%
3 Industrials 5.09%
4 Consumer Discretionary 4.89%
5 Healthcare 4.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FAN icon
6326
First Trust Global Wind Energy ETF
FAN
$285M
$295K ﹤0.01%
22,237
-69,454
-76% -$901K
MDXG icon
6327
PUT
MiMedx Group
MDXG
$622M
$295K ﹤0.01%
23,400
-4,300
-16% -$52.4K
MITK icon
6328
Mitek Systems
MITK
$877M
$295K ﹤0.01%
33,001
-14,790
-31% -$135K
ACH
6329
PUT
Accendra Health
ACH
$73.1M
$295K ﹤0.01%
+15,600
New +$346K
WOR icon
6330
CALL
Worthington Enterprises
WOR
$2.87B
$295K ﹤0.01%
+10,867
New +$290K
BEST
6331
CALL
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
$295K ﹤0.01%
+1,645
New +$347K
OSG
6332
Octave Specialty Group
OSG
$221M
$294K ﹤0.01%
18,391
-69,606
-79% -$1.07M
FMX icon
6333
Fomento Económico Mexicano
FMX
$40.3B
$294K ﹤0.01%
3,135
-150
-5% -$13.7K
XPP icon
6334
CALL
ProShares Ultra FTSE China 50 of PROSHARES TRUST
XPP
$8.31M
$294K ﹤0.01%
3,500
-2,600
-43% -$211K
PRTK
6335
PUT
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$294K ﹤0.01%
16,400
+6,800
+71% +$142K
DBD
6336
CALL
DELISTED
Diebold Nixdorf Incorporated
DBD
$294K ﹤0.01%
+18,000
New +$348K
GOGL
6337
DELISTED
Golden Ocean Group
GOGL
$293K ﹤0.01%
+35,998
New +$292K
OGS icon
6338
PUT
ONE Gas
OGS
$5.09B
$293K ﹤0.01%
4,000
-1,200
-23% -$91K
PAHC icon
6339
Phibro Animal Health
PAHC
$1.39B
$293K ﹤0.01%
+8,745
New +$311K
UFPI icon
6340
PUT
UFP Industries
UFPI
$4.96B
$293K ﹤0.01%
7,800
-600
-7% -$22.1K
AGIO icon
6341
CALL
Agios Pharmaceuticals
AGIO
$2B
$292K ﹤0.01%
5,100
-5,800
-53% -$365K
MAA icon
6342
CALL
Mid-America Apartment Communities
MAA
$15.5B
$292K ﹤0.01%
2,900
-6,800
-70% -$706K
MAIN icon
6343
Main Street Capital
MAIN
$5.5B
$292K ﹤0.01%
7,343
-3,563
-33% -$144K
NVEE
6344
CALL
DELISTED
NV5 Global
NVEE
$292K ﹤0.01%
21,600
-6,800
-24% -$92.3K
PEN icon
6345
CALL
Penumbra
PEN
$12.9B
$292K ﹤0.01%
+3,100
New +$307K
ATTO
6346
DELISTED
Atento S.A.
ATTO
$292K ﹤0.01%
+5,719
New +$305K
SYNT
6347
PUT
DELISTED
Syntel Inc
SYNT
$292K ﹤0.01%
+12,700
New +$301K
SABR icon
6348
CALL
Sabre
SABR
$900M
$291K ﹤0.01%
+14,200
New +$272K
WWE
6349
CALL
DELISTED
World Wrestling Entertainment
WWE
$291K ﹤0.01%
9,500
-2,600
-21% -$70.3K
LM
6350
DELISTED
Legg Mason, Inc.
LM
$291K ﹤0.01%
6,932
-691,253
-99% -$27.1M

Similar funds

Ken Griffin's Q4 2017 Portfolio in Review

As of Q4 2017, Ken Griffin held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Ken Griffin deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.

By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 7.2% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.

  • Ken Griffin's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
  • Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
  • Ken Griffin's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
  • Ken Griffin fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
  • Ken Griffin's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
  • Ken Griffin opened 1,440 new positions and closed 988 in Q4 2017.
  • Ken Griffin's portfolio value rose 26% quarter-over-quarter to $164B.

Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.